ClinicalTrials.gg
Drug

Cilostazol clinical trials

Also written Pletal.

studies test it
125
open now
23
in phase 3
28
first study started
1992

How each study uses Cilostazol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Cilostazol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
15 Jan 1999 · PLETAL · NDA 020863 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Cilostazol
74
Pletaal
18
Cilostazol 100 MG
15
group B
7
Treatment R
5

Brand

Pletal
12

In one entry with another drug

Given together, or one or the other

Pletaal and Changtai
2
aspirin, clopidogrel, cilostazol
2

Studies by the year they started

124 studies that test it; most in 2009 (11); 1 more planned to start later

Studies that test Cilostazol, by start year
YearStudies
19921
20012
20033
20049
20052
20064
20076
20085
200911
20106
20116
20124
20139
20142
20154
20167
20171
20184
20194
20214
202210
20235
20246
20255
20264

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
22
Phase 2
18
Phase 3
28
Phase 4
53
No phase
11

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 30 · Other 95

Kafrelsheikh University (9) · Otsuka Beijing Research Institute (5) · Genovate Biotechnology Co., Ltd., (5) · Korea Otsuka Pharmaceutical Co., Ltd. (5) · Asan Medical Center (5) · Seoul National University Hospital (4) · Samsung Medical Center (4) · Gyeongsang National University Hospital (4)

Often tested with

Tested in the same studies.

Clopidogrel (12) · Probucol (9) · Ticagrelor (6) · Aspirin (3) · Isosorbide mononitrate (2) · Simvastatin (2) · Desloratadine (1) · Dipyridamole (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5, 1 in phase 3

Studies that test Cilostazol, phase 3 first.

Studies

Open first, then newest update. How each study uses Cilostazol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 125

See all 125 studies that test Cilostazol →

Given beside what is tested · 4 — Cilostazol is usual care or a partner of the new treatment
As the comparator · 5 — what is tested is compared with Cilostazol

What changed recently

From the registry's own updates since Oct 16, 2026.

Codes

What other systems call Cilostazol · ClinicalTrials.gg INT006716

  • MeSH (NLM) D000077407CilostazolConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) N7Z035406BCILOSTAZOLConfirmed FDA, NLM, Wikidata
  • RxNorm 21107Confirmed FDA, Wikidata
  • Wikidata Q258591cilostazolConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1051CilostazolOne source FDA
  • DrugBank DB01166One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.